EUVIMEDEUVIMED entdecken
Crossref

Predictive values of the hemoglobin, albumin, lymphocyte and platelet score (HALP) and the modified -Gustave Roussy immune score for esophageal squamous cell carcinoma patients undergoing concurrent chemoradiotherapy

Yujing Shi, Gefenqiang Shen, Yuting Zeng, Mengyang Ju, Xiaojiao Chen, Chenhong He, Liang Liang, Xiaolin Ge, Xinchen Sun, Xiaoke Di

International Immunopharmacology · 2023

DOI: 10.1016/j.intimp.2023.110773 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Immunopharmacology, 2023. Verfasst von Yujing Shi und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oncology, Jurong Hospital Affiliated to Jiangsu University, Zhenjiang, Jiangsu, China. Hauptthemen laut MEDLINE: Esophageal Squamous Cell Carcinoma, Esophageal Neoplasms. Die Arbeit wurde bisher 33-mal zitiert (Crossref) und nennt 40 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The hemoglobin, albumin, lymphocyte and platelet (HALP) score and the Gustave Roussy immune score (GRIm⁃Score) are prognostic markers in several types of malignant tumors. The prognostic values of HALP score and GRIm⁃Score in concurrent chemoradiotherapy for unresectable esophageal cancer remain unknown. METHODS: We enrolled 150 esophageal squamous cell carcinoma (ESCC) patients who underwent concurrent chemoradiotherapy in our institution between 2013 and 2018. The cutoff values for HALP, and GRIm⁃Score were defined by using receiver's operating characteristic curves. Survival was analyzed with the Kaplan- Meier method, with differences analyzed with the log-rank test. Multivariate Cox proportional-hazards models were used to evaluate the prognostic significance of HALP and GRIm for ESCC. RESULTS: HALP was significantly associated with the Zubrod ECOG WHO performance status, tumor location, and the clinical tumor, node, metastasis stage. Modified GRIm (mGRIm) was only significantly associated with metastasis / recurrence before radiotherapy (χ2 = 6.25). Univariate Cox regression analysis showed that higher mGRIm (HR 1.9 95%CI 1.3-2.9) and lower HALP (HR 2.4 95%CI 1.6-3.7) were all associated with worse OS. Multivariate COX analysis found that higher mGRIm score (HR 1.7 95%CI 1.1-2.6), and lower HALP score (HR 2 95%CI 1.3-3.2) were both independent risk factors of overall survival. The nomogram c-index in inside validation was 0.66. CONCLUSION: Both HALP and mGRIm are independent prognostic factors for patients with unresectable ESCC.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Esophageal Squamous Cell CarcinomaEsophageal NeoplasmsHumansAlbuminsLymphocytesPrognosisChemoradiotherapyHemoglobinsRetrospective Studies

Stichwörter der Autor:innen

Concurrent chemoradiotherapyEsophageal squamous cell carcinomaHALP scoreModified-Gustave-Roussy Immunity (mGRIm) scoreNutrition and inflammatory

Substanzen

AlbuminsHemoglobins

Autor:innen und Institutionen

  • Department of Oncology, Jurong Hospital Affiliated to Jiangsu University, Zhenjiang, Jiangsu, China.
  • Department of Radiotherapy Oncology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu, China.
  • Department of Radiation Oncology, Guizhou Province People Hospital, Guiyang, Guizhou, China.
  • Department of Radiation Oncology, Osaka University, Suita, Osaka, Japan.
  • Department of Radiotherapy Oncology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu, China. Electronic address: sunxinchen1919@163.com.
  • Department of Radiotherapy Oncology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu, China. Electronic address: dixiaoke@njmu.edu.cn.

Zitieren

APA

Shi, Y., Shen, G., Zeng, Y., Ju, M., Chen, X., He, C., Liang, L., Ge, X., Sun, X., & Di, X. (2023). Predictive values of the hemoglobin, albumin, lymphocyte and platelet score (HALP) and the modified -Gustave Roussy immune score for esophageal squamous cell carcinoma patients undergoing concurrent chemoradiotherapy. International Immunopharmacology. https://doi.org/10.1016/j.intimp.2023.110773

Vancouver

Shi Y, Shen G, Zeng Y, Ju M, Chen X, He C, et al. Predictive values of the hemoglobin, albumin, lymphocyte and platelet score (HALP) and the modified -Gustave Roussy immune score for esophageal squamous cell carcinoma patients undergoing concurrent chemoradiotherapy. International Immunopharmacology. 2023. doi:10.1016/j.intimp.2023.110773

BibTeX
@article{Shi2023,
  author = {Shi, Yujing and Shen, Gefenqiang and Zeng, Yuting and Ju, Mengyang and Chen, Xiaojiao and He, Chenhong and Liang, Liang and Ge, Xiaolin and Sun, Xinchen and Di, Xiaoke},
  title = {Predictive values of the hemoglobin, albumin, lymphocyte and platelet score (HALP) and the modified -Gustave Roussy immune score for esophageal squamous cell carcinoma patients undergoing concurrent chemoradiotherapy},
  journal = {International Immunopharmacology},
  year = {2023},
  doi = {10.1016/j.intimp.2023.110773}
}
Kostenlos starten →